We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Braveheart Investment Group Plc | LSE:BRH | London | Ordinary Share | GB00B13XV322 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.25 | 6.00 | 6.50 | 6.25 | 6.25 | 6.25 | 11,366 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Management Services | 51k | 1.59M | 0.0249 | 2.51 | 3.98M |
From Apr 2019 to Apr 2024
TIDMBRH
RNS Number : 5416Q
Braveheart Investment Group plc
13 September 2017
Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.
13 September 2017
Braveheart Investment Group plc
("Braveheart" or "the Company")
Update re. Portfolio investment
Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, announces that one of its Strategic Investments, Kirkstall Limited, a biotechnology company operating within the global organ-on-a-chip market, has commenced an investor marketing exercise. The board of Kirkstall is seeking to raise up to GBP2.5 million in a private placing at a pre-money valuation of GBP5.6 million.
Braveheart currently holds 43.36 per cent. of the issued share capital (37.65 per cent. on a fully diluted basis) and its carrying value in the consolidated balance sheet as at 31 March 2017 was GBP287,000, the original cost price of the investment. Braveheart does not currently intend to participate in the placing.
There can be no certainty that the fundraising by Kirkstall Limited will be completed, how much will be raised or, if a placing is completed, at what pre-money valuation the placing will be effected at.
A further announcement will be made in due course.
Further information:
Braveheart Investment Group plc
Trevor Brown, Chief Executive Tel: +44 1738 587555
Allenby Capital Limited (Nominated Adviser and Broker to Braveheart)
David Worlidge / James Thomas Tel: +44 20 3328 5656
This information is provided by RNS
The company news service from the London Stock Exchange
END
UPDUUASRBNAKAAR
(END) Dow Jones Newswires
September 13, 2017 02:00 ET (06:00 GMT)
1 Year Braveheart Investment Chart |
1 Month Braveheart Investment Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
